Altay Therapeutics
Unlocking Transcription Factors to Address Unmet Medical Need
6 employees · est. 2019 · San Francisco, United States
Renasant Bio is the larger of the two.
Side-by-Side Comparison
| Metric | Altay Therapeutics | Renasant Bio |
|---|---|---|
| Founded | ||
| Founded | 2019 | Not tracked yet |
| Headquarters | ||
| Headquarters | San Francisco, United States | Berkeley, United States |
| Employees | ||
| Employees | 6 | 33 larger |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Biotechnology |
| Funding Stage | ||
| Funding Stage | Seed | Seed |
| Total Funding | ||
| Total Funding | $3.37M | $54.50M |
| Funding Rounds | ||
| Funding Rounds | 7 | 1 |
| Services | ||
| Services | Development of oral transcription factor inhibitors, Drug discovery and development, Precision medicine for underserved diseases | Development of small molecule correctors and potentiators, Restoration of PC1/2 protein function, Disease-modifying therapy development for ADPKD |
| Target Customers | ||
| Target Customers | Patients with FSHD, Cancer patients, Patients with chronic inflammatory diseases, Medical researchers | Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD), Biopharma researchers, Healthcare providers specializing in renal diseases |
| Taxonomy | ||
| Taxonomy | Small Molecule Drugs, Drug Development, Transcription Factors, Chronic Illnesses, Cancers, Disease Treatment, Pharmaceuticals, Drug Targeting, Biomedical Research | Biopharmaceutical, ADPKD Treatment, Disease-Modifying Therapies, Oral Small Molecules, Genetic Disease, End-Stage Renal Failure, Protein Function Restoration, Drug Development, Polycystic Kidney Disease, Biomedical Innovation, Small Molecule Correctors, Small Molecule Potentiators |
| Website | ||
| Website | altaytherapeutics.com | renasantbio.com |
About Altay Therapeutics
Altay Therapeutics, headquartered in the United States, is a promising player in the Biotechnology and Life Sciences sectors. Founded in 2019, the company specializes in the development of novel small molecule drugs targeting disease-causing transcription factors, aiming to treat chronic illnesses a...
About Renasant Bio
Renasant Bio, with its slogan "Transforming the Treatment of ADPKD," is making significant strides in the Biotechnology sector. The company is dedicated to developing disease-modifying oral small molecule treatments specifically for autosomal dominant polycystic kidney disease (ADPKD), a leading gen...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at Altay Therapeutics and Renasant Bio — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at Altay Therapeutics and Renasant Bio — by email.
Frequently Asked Questions
Compare Altay Therapeutics with someone else
Start typing a company name or domain.